Development asset linked to Rocket Pharmaceuticals in public FDA and regional records.
pharma · Rectal Cancer · Fanconi Anemia · RCKT
Rocket Pharmaceuticals
Rocket Pharmaceuticals B.V.
Rocket Pharmaceuticals drug portfolio — 10 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
9 Cedarbrook Dr, Cranbury, New Jersey 08512, US HQ
2015 Founded
226 Employees
Public company Type
RCKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- 9 Cedarbrook Dr, Cranbury, New Jersey 08512, US
- Founded
- 2015
- Employees
- 226
- Programs
- 11
- Drugs
- 10
- Patents
- 1
Rocket Pharmaceuticals pipeline
Portfolio lens on 10 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Rocket Pharmaceuticals drug portfolio — 10 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor alpha agonist
-
filgrastim
Antineoplastic and immunomodulating agents (L03)US regulatory status: approved. Molecular target: Granulocyte colony-stimulating factor receptor.
- Target
- Granulocyte colony-stimulating factor receptor
- Mechanism
- Granulocyte colony stimulating factor receptor agonist
-
Development asset linked to Rocket Pharmaceuticals in public FDA and regional records.
-
human heterologous liver cells
Alimentary tract and metabolism (A16)Alimentary tract and metabolism (A16) compound in Rocket Pharmaceuticals's portfolio.
-
Development asset linked to Rocket Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Rocket Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Rocket Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Rocket Pharmaceuticals in public FDA and regional records.
-
Development asset linked to Rocket Pharmaceuticals in public FDA and regional records.